PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.98%
Negative revenue growth while MRVL stands at 12.99%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-10.41%
Negative gross profit growth while MRVL is at 10.91%. Joel Greenblatt would examine cost competitiveness or demand decline.
-26.33%
Negative EBIT growth while MRVL is at 58.34%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-26.33%
Negative operating income growth while MRVL is at 58.34%. Joel Greenblatt would press for urgent turnaround measures.
-12.97%
Negative net income growth while MRVL stands at 65.40%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-12.12%
Negative EPS growth while MRVL is at 57.20%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-12.50%
Negative diluted EPS growth while MRVL is at 79.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.35%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
22.65%
Dividend growth of 22.65% while MRVL is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
38.54%
OCF growth above 1.5x MRVL's 25.54%. David Dodd would confirm a clear edge in underlying cash generation.
78.76%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
-2.53%
Negative 10Y revenue/share CAGR while MRVL stands at 179.58%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
16.81%
5Y revenue/share CAGR under 50% of MRVL's 179.58%. Michael Burry would suspect a significant competitive gap or product weakness.
63.75%
3Y revenue/share CAGR under 50% of MRVL's 179.58%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
160.39%
10Y OCF/share CAGR under 50% of MRVL's 842.49%. Michael Burry would worry about a persistent underperformance in cash creation.
34.06%
Below 50% of MRVL's 842.49%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
55.27%
3Y OCF/share CAGR under 50% of MRVL's 842.49%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
124.14%
Net income/share CAGR 1.25-1.5x MRVL's 104.35%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
7.41%
Below 50% of MRVL's 104.35%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
492.03%
3Y net income/share CAGR above 1.5x MRVL's 104.35%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
269.66%
Positive growth while MRVL is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
41.08%
Positive 5Y equity/share CAGR while MRVL is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
2.06%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
64.52%
Dividend/share CAGR of 64.52% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
29.35%
Dividend/share CAGR of 29.35% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
13.43%
3Y dividend/share CAGR of 13.43% while MRVL is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-13.69%
Firm’s AR is declining while MRVL shows 13.90%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.37%
Inventory is declining while MRVL stands at 19.26%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.00%
Asset growth well under 50% of MRVL's 3.58%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.65%
Under 50% of MRVL's 4.17%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-1.04%
We’re deleveraging while MRVL stands at 18.58%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.04%
R&D dropping or stable vs. MRVL's 8.26%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.72%
SG&A growth well above MRVL's 4.07%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.